Harvard Bioscience
HBIO
HBIO
84 hedge funds and large institutions have $87.8M invested in Harvard Bioscience in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
32% less capital invested
Capital invested by funds: $129M → $87.8M (-$41.2M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $36K
Holders
84
Holding in Top 10
1
Calls
–
Puts
$36K
Top Buyers
| 1 | +$2.78M | |
| 2 | +$1.04M | |
| 3 | +$911K | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$748K |
| 5 |
Goldman Sachs
New York
|
+$663K |
Top Sellers
| 1 | -$1.74M | |
| 2 | -$1.43M | |
| 3 | -$1.26M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$624K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$562K |